SHALBY
|
SHALBY Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 6.31 | 5.01 | 3.93 | 2.55 | 2.93 |
| CEPS(Rs) | 10.79 | 8.97 | 7.33 | 5.89 | 6.00 |
| DPS(Rs) | 1.20 | 1.00 | 1.00 | 0.50 | 0.50 |
| Book NAV/Share(Rs) | 86.37 | 81.13 | 77.28 | 74.00 | 72.20 |
| Tax Rate(%) | 33.68 | 31.81 | 23.06 | 51.37 | 37.18 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.17 | 17.39 | 20.27 | 17.00 | 18.06 |
| EBIT Margin(%) | 13.99 | 12.40 | 13.83 | 13.17 | 12.89 |
| Pre Tax Margin(%) | 12.68 | 11.32 | 12.78 | 11.65 | 10.90 |
| PAT Margin (%) | 8.41 | 7.72 | 9.83 | 5.67 | 6.85 |
| Cash Profit Margin (%) | 14.38 | 13.86 | 18.37 | 13.06 | 14.02 |
| Performance Ratios | |||||
| ROA(%) | 5.06 | 4.60 | 4.05 | 2.72 | 3.12 |
| ROE(%) | 7.51 | 6.31 | 5.19 | 3.49 | 4.13 |
| ROCE(%) | 10.72 | 9.08 | 6.85 | 7.49 | 6.94 |
| Asset Turnover(x) | 0.60 | 0.60 | 0.41 | 0.48 | 0.46 |
| Sales/Fixed Asset(x) | 0.91 | 0.84 | 0.54 | 0.63 | 0.63 |
| Working Capital/Sales(x) | 2.49 | 2.59 | 2.28 | 3.24 | 4.25 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.10 | 1.19 | 1.84 | 1.59 | 1.58 |
| Receivable days | 47.01 | 51.09 | 80.28 | 66.06 | 52.21 |
| Inventory Days | 69.50 | 37.64 | 16.21 | 10.51 | 9.82 |
| Payable days | 492.96 | 761.23 | 619.39 | 401.50 | 489.09 |
| Valuation Parameters | |||||
| PER(x) | 21.33 | 23.31 | 25.69 | 18.13 | 44.09 |
| PCE(x) | 12.48 | 13.03 | 13.76 | 7.86 | 21.53 |
| Price/Book(x) | 1.56 | 1.44 | 1.31 | 0.63 | 1.79 |
| Yield(%) | 0.89 | 0.86 | 0.99 | 1.08 | 0.39 |
| EV/Net Sales(x) | 1.96 | 1.87 | 2.44 | 1.10 | 3.12 |
| EV/Core EBITDA(x) | 9.79 | 9.75 | 10.89 | 5.33 | 15.54 |
| EV/EBIT(x) | 13.98 | 15.07 | 17.61 | 8.32 | 24.20 |
| EV/CE(x) | 1.13 | 1.02 | 0.98 | 0.52 | 1.44 |
| M Cap / Sales | 1.79 | 1.80 | 2.53 | 1.03 | 3.02 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.16 | 62.21 | -11.49 | 5.32 | 22.29 |
| Core EBITDA Growth(%) | 19.93 | 39.01 | -3.76 | 8.00 | 4.26 |
| EBIT Growth(%) | 29.91 | 45.45 | -7.08 | 7.68 | -9.88 |
| PAT Growth(%) | 25.40 | 27.40 | 53.56 | -12.85 | -19.19 |
| EPS Growth(%) | 25.90 | 27.66 | 53.67 | -12.86 | -19.60 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.15 | 0.18 | 0.05 | 0.08 | 0.09 |
| Current Ratio(x) | 2.66 | 2.56 | 3.32 | 2.81 | 2.23 |
| Quick Ratio(x) | 1.71 | 1.86 | 3.03 | 2.62 | 2.09 |
| Interest Cover(x) | 10.66 | 11.51 | 13.13 | 8.66 | 6.49 |
| Total Debt/Mcap(x) | 0.10 | 0.12 | 0.04 | 0.12 | 0.05 |
Compare Financial Ratios of peers of SHALBY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHALBY | ₹3,017.5 Cr | 2.1% | 15% | 95.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹89,988.4 Cr | 0.4% | -1.8% | 45% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹77,986.2 Cr | 5.8% | 8.5% | 78.4% | Stock Analytics | |
| GLOBAL HEALTH | ₹38,865.1 Cr | 1.8% | 12.9% | 194.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹33,501.3 Cr | 0.5% | 9.7% | 66.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹26,073.4 Cr | 1.5% | 3.5% | 63.9% | Stock Analytics | |
SHALBY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHALBY | 2.1% |
15% |
95.2% |
| SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses
